人乳头瘤病毒(HPV)疫苗的研究进展  

Research Progress of Human Papillomavirus Vaccine

作　　者：胡彬 柳露[1] 潘慧敏 张旭梅[1] 

机构地区：[1]昆明医科大学附属延安医院妇科,云南昆明

出　　处：《临床医学进展》2019年第8期1013-1017,共5页Advances in Clinical Medicine

摘　　要：宫颈癌在全球女性恶性肿瘤中排列第四位,严重威胁女性健康。高危型HPV持续感染是导致宫颈癌的主要原因,预防性HPV疫苗可以减少宫颈癌的发生,但无法治疗已经感染或病变的组织,治疗性HPV疫苗的研发目前是研究热点。Cervical cancer is the fourth malignant tumor of women in the world,which seriously threatens women’s health.The persistent infection of high-risk HPV is the main cause of cervical cancer.Prophylactic HPV vaccine can reduce the occurrence of cervical cancer,but cannot treat the tissues that have been infected or diseased.The research and development of therapeutic HPV vaccine is currently a research hotspot.

关 键 词：人乳头瘤病毒 疫苗 预防性疫苗 治疗性疫苗 

分 类 号：R73[医药卫生—肿瘤]